| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000008328 |
| Receipt No. | R000009737 |
| Official scientific title of the study | Detection of histological type and genetic mutation in lung cancer using ion mobility spectrometry |
| Date of disclosure of the study information | 2012/07/03 |
| Last modified on | 2018/07/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Detection of histological type and genetic mutation in lung cancer using ion mobility spectrometry | |
| Title of the study (Brief title) | Diagnosis of lung cancer using IMS | |
| Region |
|
|
| Condition | ||
| Condition | To investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer. | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To identify specific VOC patterns in patients with lung cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Lung cancer:
To collect 10ml of exhaled air using BioScout. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) No treatment of lung cancer
2) To agree to give informed consent |
|||
| Key exclusion criteria | 1) To refuse to give informed consent
2) Lung cancer of unknown histological type 3) Patients with no diagnosis of lung cancer 4) Patients who are pregnant, possibly pregnant, or lactating. 5) Patients with renal failure. (serum creatinine > 2.0 mg/dL, BUN > 30mg/dl) 6) AST or ALT > 100IU 7) Patients with severe diabetes, hyperlipidemia or hyperuricemia 8) Patients who are judged inappropriate by the doctor in charge. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Teruomi Miyazawa |
| Organization | St. Marianna University School of Medicine
Division of Respiratory and Infectious Diseases, Department of Internal Medicine |
| Division name | Division of Respiratory and Infectious Diseases, Department of Internal Medicine |
| Address | 2-16-1 Sugao Miyamae-ku, Kawasaki, Kanagawa, Japan 216-8511 |
| TEL | 044-977-8111 |
| Public contact | |
| Name of contact person | Hiroshi Handa |
| Organization | St. Marianna University School of Medicine |
| Division name | Division of Respiratory and Infectious Diseases, Department of Internal Medicine |
| Address | 2-16-1 Sugao Miyamae-ku, Kawasaki, Kanagawa, Japan 216-8511 |
| TEL | 044-977-8111 |
| Homepage URL | |
| Sponsor | |
| Institute | St. Marianna University School of Medicine
Division of Respiratory and Infectious Diseases, Department of Internal Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | St. Marianna University School of Medicine
Division of Respiratory and Infectious Diseases, Department of Internal Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009737 |